mouth cancer Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1 (1)
Phase 2 (1)

Interventional (2)

Radboud University (1)
Shanghai Jiao Tong University School of Medicine (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadct scan

I am/have/hadchemoradiotherapy

I am/have/hadsquamous cell carcinoma

I am/have/hadcarcinoma

I am/have/hadsalivary gland cancer

I am/have/hadleukocyte count

I am/have/hadgilbert's syndrome

I am/have/hadlymph node metastases

I am/have/hadneovascularization

I am/have/hadimmunosuppression

I am/have/hadangiogenesis

I am/have/hadvascular endothelial growth factor

I am/have/hadmeasurable disease

I am/have/hadtargeted therapy

I am/have/hadtumor growth

I am/have/hadmetastasis

I am/have/hadrenal function

I am/have/hadtumor angiogenesis

I am/have/hadhead and neck squamous cell carcinoma

I am/have/hadcancer

added new label for I am/have/had

more

I am looking for

I am looking forcamrelizumab

I am looking forvascular endothelial growth factor

I am looking forimmune checkpoint inhibitor

I am looking forapatinib

I am looking forgrowth factor

I am looking forvegf

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma

In patients with locally advanced oral squamous cell carcinoma (OSCC), due to the large tumor burden and neck lymph node metastasis, comprehensive treatment is recommended, including surgery, radiotherapy, chemotherapy and others. Pre-operative inductive therapy can reduce tumor volume, increase organ retention rate, and reduce distant metastasis rate. Vascular endothelial growth …

chemoradiotherapy

squamous cell carcinoma

carcinoma

leukocyte count

apatinib

0 views
19 Feb, 2024

Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients

Phase 2 pilot study, which evaluates the safety and efficacy of Lutetium-177-PSMA radioligand therapy in advanced salivary gland cancer patients.

ct scan

metastasis

salivary gland cancer

gilbert's syndrome

liver metastasis

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.